Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BTK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | ZRANB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | HIGD1A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | AURKAIP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | ZNF568 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | YJEFN3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | FRYL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | EPX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | TCL1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | HS3ST2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |